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Unregulated ionic pathwayAtaxin 1 (ATXN1) is the protein involved in spinocerebellar ataxia type 1, one of nine dominantly inherited
neurodegenerative diseases triggered by polyglutamine expansion. One of the isolated polyglutamine tracts
properties is to interact with lipid bilayers. Here we used a multidisciplinary approach to test whether one of
the mechanisms responsible for neuronal degeneration involves the destabilization of the nuclear mem-
brane. We thus analyzed the interaction between ATXN1 and lipid membranes, both on cellular models
and on artiﬁcial lipid bilayers, comparing pathological expanded polyglutamine and histidine interrupted
non-harmful polyglutamine tracts of the same length. The toxicity of the different constructs was tested in
transiently transfected COS1 cells. Cells expressing pathological ATXN1 presented a signiﬁcantly higher fre-
quency of anomalous nuclei with respect to those expressing non-harmful ATXN1. Immunoﬂuorescence
and electron microscopy showed severe damage in the nuclear membrane of cells expressing the patholog-
ical protein. Atomic force microscopy on artiﬁcial membranes containing interrupted and non-interrupted
partial ATXN1 peptides revealed a different arrangement of the peptides within the lipid bilayer. Force-
distance measurements indicated that membrane fragility increases with the lengthening of the uninter-
rupted glutamine. Transmembrane electrical measurements were performed on artiﬁcial bilayers and on
the inner nuclear membrane of ATXN1 full length transfected cells. Both artiﬁcial lipid bilayers and cellular
models demonstrated the dynamic appearance of ionic pathways. Uninterrupted polyglutamines showed
not only a larger ionic ﬂow, but also an increase in the single event conductance. Collectively, our results sug-
gest that expanded ATXN1 may induce unregulated ionic pathways in the nuclear membrane, causing severe
damage to the cell.
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Spinocerebellar ataxia type 1 (SCA1; OMIM ID: 164400) is an au-
tosomal dominant cerebellar ataxia characterized by a progressive
loss of motor coordination, speech impairment, and problems
with swallowing. It is associated to a (CAG)n expansion in the SCA1
gene.
SCA1 is one of nine unrelated genes responsible for inherited dis-
eases known as polyglutamine (polyQ) neurodegenerative disorders
[1]. The mutational mechanism of these diseases is the expansion of
a polymorphic CAG trinucleotide repeat that encodes a polyQ stretch
in each causative gene. These disorders are Huntington disease (HD),
spinal bulbar muscular atrophy (SBMA or Kennedy's disease), denta-
torubropallidoluysian atrophy (DRPLA), and six dominantly inherited
spinocerebellar ataxias (SCA1-3, SCA6, SCA7 and SCA17).
907L. Mapelli et al. / Biochimica et Biophysica Acta 1822 (2012) 906–917Normal SCA1 alleles contain from 6 to 45 CAG repeats, with those
greater than 21 being always interrupted with 1–3 CAT trinucleotides
[2–4]. By contrast, disease alleles are pure CAG tracts ranging from 39
to 82 units. The length of the repeat tract is a major contributor to the
age of disease onset [5,6]. Typically the onset in individuals carrying a
mutant SCA1 allele (40–50 repeats) is in their forties or ﬁfties, but in-
dividuals with >70 repeat units have a juvenile form of SCA1 and
show symptoms starting as early as the age of ten. By the age of
sixty disease penetrance is essentially complete (for a review see
[7,8]).
SCA1 encodes for a protein, ataxin 1 (ATXN1), that localizes in the
nucleus through a functional nuclear localization signal (NLS) [9]. In-
activation of the NLS in an expanded ATXN1 results in a mutant pro-
tein that is no longer pathogenic [9]. This result, on the one hand,
indicates that the ability of mutant ATXN1 to cause disease might
be linked to its localization in the nucleus; on the other hand, it sup-
ports the conclusion that the toxicity of the expanded SCA1 allele is
mediated at the protein level rather than at the RNA one.
Genetic studies have shown that expansion of the polyQ tract con-
fers a toxic gain of function [10–15]. In particular, it seems unlikely
that expansion of the polyQ eliminates ATXN1 normal function
which is critical for Purkinje cells. In fact, mice lacking Atxn1 do not
develop ataxia and Purkinje cell pathology [12]. On the other hand,
these cerebellar disorders have been observed in mice overexpressing
mutant ATXN1 [16] or knock-in mice expressing Atxn1 with an ex-
panded polyglutamine tract [16]. However, the nature of this gain of
function remains unexplained.
Although ATXN1 is widely expressed [17,18], mutant ATXN1
mainly causes neurodegeneration of cerebellar Purkinje cells, brain
stem and spinal cord neurons. The selective neurotoxicity observed
in SCA1 and other polyQ diseases, such as SBMA and HD, [19] could
be due to protein domains outside the polyQ tract which play an im-
portant role in making the polyQ tract expansion necessary but not
sufﬁcient to cause pathology. In fact, evidence has been reported
about the loss of function resulting from a defective interaction be-
tween expanded ATXN1 and speciﬁc proteins [9,20–24]. In particular,
it has been shown that ATXN1 interacts with the RNA-binding motif
protein 17 (RBM17) in a Ser776 and polyQ length-dependent fashion
[25]. However, recently it has been found that ATXN1[30Q] with
Ser776 replaced by Asp induces disease in Purkinje cells of transgenic
mice as ATXN1[82Q], but fails to progress into neuronal degeneration
[26].
It has been proposed that one of the mechanisms responsible for
neuronal degeneration could involve the ability of isolated polyQ
tracts to form large non-selective ion channels in planar lipid bilayers
[27,28]. Moreover, when polyQ expansions are part of speciﬁc pro-
teins, such as the huntingtin N-terminal fragment (htt1-89), they
favor the association with phospholipids and membrane insertion
[29].
In an effort to address the question whether polyQs, and more
speciﬁcally expanded ATXN1, are prone to form anomalous mem-
brane associations, we decided to analyze the effects of the expanded
polyQ ATXN1 on the nuclear membrane. The analyses have been car-
ried out in vitro and in vivo by comparing the results of various exper-
iments performed with both normal ATXN1 variants, containing 31
and 45 repeats of glutamines interrupted by residues of histidine
(31Q(H) and 45Q(H)), and pathological variants, containing 45 and
76 repeated glutamines (45Q and 76Q).
This research was carried out using a multidisciplinary approach.
Electrophysiological experiments provided evidence that the interac-
tion of uninterrupted partial ATXN1 peptide (pATXN1-Q) with artiﬁ-
cial lipid bilayers causes a much higher increase of ionic membrane
conductance with respect to interrupted partial ATXN1 peptide
(pATXN1-QH). Force-distance curves measured by using the atomic
force microscope (AFM) showed that the presence of polyQ tracts
causes a decrease of the mechanical resistance of artiﬁcial lipidbilayers. This effect was much more pronounced for pATXN1-Q. Fur-
ther experiments were performed with full length ATXN1 protein.
We applied single channel recording on the inner nuclear membrane
of ataxin-1 full length transfected cells. The pathological form (45Q in
the present case) caused multiple ionic conductance compared to
paucity of current levels of polyQ(H). Furthermore, the conductance
induced by polyQ was modulated by Ca++ concentration, whereas
it was practically insensitive to Ca++ concentration in the presence
of polyQ(H). Finally, both electron microscopy and confocal images
showed severe damage in the nuclear envelope of cells expressing ex-
panded ATXN1-Q. In contrast, nuclei of cells transfected with non-
pathological ATXN1 displayed a less extended damage to the
membrane.
All these sets of data support the idea that uninterrupted expand-
ed polyQs, either analyzed as recombinant peptides or as a full length
protein, are able to insert themselves into lipid membranes causing
both conductance increase and membrane destabilization. Due to
the signiﬁcant interplay between the inner nuclear membrane and
the heterochromatin stabilization [30,31], we suggest that the pro-
gressive and inexorable degeneration caused by polyglutamine disor-
ders derives from the nuclear envelope loss of function.
2. Materials and methods
2.1. Plasmids and polypeptides preparation
Constructs expressing partial ATXN1 peptides, whose se-
quences are: pATXN1-32Q(H)→aa34-Q14HQHQ15-aa47; pATXN-
45Q(H)→aa34-Q12HQHQ12HQHQ15-aa47; pATXN-45Q→aa34-Q45-aa47
and pATXN-76Q→aa34-Q76-aa47, have been described [2].
Escherichia coli BL21 carrying the pGEX expression plasmids of in-
terest were grown to an O.D.600 of 0.6–1.0 at 30 °C (the low incuba-
tion temperature reduces the level of instability), and induced with
IPTG [1 mM pGEX-poly32Q(H), pGEXpoly45Q(H) and pGEX-
poly45Q, and 0.1 mM pGEX-poly76Q] for 3.5 h as described by the
manufacturer (Amersham-Pharmacia). Cultures (30 ml) of induced
bacteria were centrifuged for 15 min, and the resulting pellets were
resuspended in 1.5 ml of lysis buffer [phosphate buffered saline
(PBS) 1×] containing 0.1 mg/ml lysozyme and 0.01 mg/ml DNase I,
and stored overnight at −20 °C. Cells were lysated with 10 freeze/
thaw cycles, and the resulting lysates were clariﬁed by centrifugation
in a microfuge at 13,000 rpm for 10 min. Cleared lysates were incu-
bated overnight at 4 °C with 100 μl of a 50% slur of glutathione
sepharose 4B. The beads were washed three times and resuspended
in lysis buffer (PBS 1×). The bound GST-polyQ fusion proteins were
eluted with 100 μl of glutathione elution buffer (10 mM reduced glu-
tathione). Protein concentrations were determined by the Bio-Rad
(Germany) dye binding assay using bovine serum albumin as
standard.
Full-length ATXN1 cDNAs containing 32Q(H), -45Q(H), 45Q and
76Q(H) polyglutamine stretches were cloned in both pEGFP-N3 and
pIRES2-EGFP (Clontech) plasmids for expression in mammalian cells.
2.2. Transfection and immunocytochemistry
COS1 cell lines were maintained in Dulbecco's minimal essential
medium (DMEM) enriched with 10% fetal calf serum (FCS). Transient
transfection experiments were performed in 60 mm plates using 1 μg
of DNA combined with DNA Plus and Lipofectamine reagents. Cells
were ﬁxed with 4% paraformaldehyde and/or lysed with PBS supplied
with 0.2% Triton-X 100, 48 h post-transfection. For immunocyto-
chemical labeling, cells were cultured on glass coverslips. Forty-
eight hours post-transfection, cells expressing the EGFP-ATXN1 fu-
sion proteins were washed once with 1× phosphate buffered saline
(PBS) and ﬁxed in 4% paraformaldehyde for 15 min. The cover slips
were mounted on slides and the cells were visualized using a
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cence is excited at 488 nm and its emission examined at 516 nm).
Immunodetection of emerin was done using a polyclonal antibody
against emerin (kindly supplied by Dr. Toniolo; [32]) at 1:100.
2.3. Quantiﬁcation of aggregate formation and abnormal cell nuclei
Aggregate formation and nuclear morphology were assessed using
a ﬂuorescence microscope. For each type of transfection, more than
400 EGFP-positive COS1 cells were selected and the proportion of
cells with abnormal nuclei and/or aggregates was counted, as well
as the size of the aggregates themselves. Cells were considered abnor-
mal if the DAPI-stained nuclei showed apoptotic morphology (frag-
mentation or pyknosis) [33] and absence of total overlap between
the normal ATXN1 localization in the nucleus (green ﬂuorescence)
and the chromatin material (DAPI staining).
2.4. Transmission electron microscopy
Transmission electron microscopy analysis was undertaken on
transfected COS1 cells with pEGFP-ATXN1-32Q(H), -45Q(H), 45Q
and 76Q(H), as well as empty pEGFP-N3 as control. Cells were ﬁxed
with 2.5% glutaraldehyde in 0.1 M cacodylate buffer for 1 h at 4 °C.
Post ﬁxation was performed with 1% OsO4. Samples were then dehy-
drated in a graded ethanol series and embedded in Spurr resin. Ultra-
thin sections were stained with 2% uranyl acetate and observed under
a Zeiss EM900 transmission electron microscope. Images were cap-
tured digitally with a Mega View II digital camera (SIS).
2.5. Preparation of supported lipid bilayers
Unilamellar vesicles containing pATXN1 peptides embedded in
the membrane were obtained by hydrating a mixture of
diphytanoyl-phosphatidylcholine and pATXN1-31Q(H), -45Q(H), or
-45Q. The lipid concentration was 1.2 mM, while the protein concen-
tration was 1.5 nM. The hydration process was performed at room
temperature in distilled water, with the aid of an ultrasonic bath
(ACAD, Genoa, Italy) for 10 min. Then the sample was sonicated
with a tip sonicator (Ultrasonics Ltd., Northants, UK) for 40 min; to
prevent overheating the sample was immersed in a water bath kept
at 20 °C. To remove large lipid aggregates and titanium impurities re-
leased by the tip, the suspension was centrifuged for 10 min at
11,500×g in a Sorvall RC-SB Superspeed Centrifuge (Du Pont Instru-
ments, Newton, CT). Supported lipid bilayers were prepared via vesi-
cle fusion on freshly cleaved mica substrates. The liposome solution
was incubated on the mica surface at room temperature for 1.0 h;
then the sample was rinsed and allowed to equilibrate for 2 h. All
the AFM experiments were performed in distilled water.
2.6. Atomic force microscopy
AFM experiments were carried out using a NanoWizard II system
(JPK Instruments, Berlin, Germany), working under distilled water at
room temperature. V-shaped standard silicon nitride cantilevers
with a nominal spring constant of 0.32 N/m (NP, Veeco, Woodbury,
NY; US) were used both for imaging and bilayers rupture force mea-
surements. Images were collected working in tapping mode to mini-
mize the lateral force applied to the sample during scanning. Typical
scan rates were between 0.5 and 1.5 Hz. The drive amplitude was set
between 0.6 and 1.5 V to induce a free amplitude oscillation of 0.7 V
RMS. The tip resonance frequency was in the range between 10 and
12 kHz. Due to tip size effects, which cause an apparent increase of
the size of the imaged object in the image plane, island widths mea-
sured from AFM images are overestimated as compared to the
real ones. To evaluate the expected width, w, we used the equationw ¼ wmeas þ 2h−2
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
h2 þ 2Rh
p
where wmeas is the measured island
width, h is the measured island height and R the AFM tip radius.
To obtain the breakthrough force the spring constant of each can-
tilever was determined in situ before and after every experiment,
using the thermal noise method [34]. The indenting speed was main-
tained constant to 1 μm/s in all the experiments to avoid any effect of
the speed when comparing the bilayer rupture forces. The experi-
ments were performed on at least three different samples for each
protein species. For each single experiment 150–300 force curves
were collected, indenting the bilayer in different positions. A custom
routine for force curve analysis working in MatLab environment
was developed [35] the software automatically detects the yielding
force for each single curve and displays the result graphically as
shown in Fig. 4A.2.7. Electrophysiological assay
Single-channel recordings from lipid bilayer were obtained by
using the Tip–Dip method. In brief, patch clamp pipettes (Garner
Glass 7052) were made using a P97 Sutter Instruments puller (Novato,
CA), coated with Sylgard (Dow Corning, Midland, MI) and ﬁre-
polished to a tip diameter of 1–1.5 μm and 5–7 MΩ resistance. As
soon as the pipette tip reached the bath solution, a 1,2-diphytanoyl-
sn-glycero-3-phosphocholine (Diph-PC, Avanti Polar Lipids, Inc.,
Birmingham, AL) monolayer was spread on the surface. The electrode
was repeatedly passed through the surface of the bath chamber solu-
tion until the pipette resistance rose above 5 GΩ. The lipid bilayer was
regularly tested for a period of 10–15 min to search for unspeciﬁc
electric current. An Axopatch 1D ampliﬁer and pClamp 8 (both from
Molecular Device, Novato, CA) were used to record and analyze the
single-channel currents. Current recordings were digitized at 5 kHz
and ﬁltered at 1000 Hz.
In almost all the experiments the same buffer was employed in the
two compartments. The “trans” and “cis” solutions were 144 mM KCl,
0.1 mM CaCl2, 1.2 mM MgCl2, 1.1 EGTA, 10 mM Hepes, and pH 6.2.
Occasionally to check membrane selectivity the “trans” solution
adopted was 144 mM NaCl, 1.8 mM CaCl2, 1.2 mM MgCl2, 10 mM
Hepes, and pH 7.0. Membrane voltages (Vm) and ion currents were
relative to the solution inside the glass pipette: as an example, an in-
ward current is deﬁned as a cation moving from the electrode to the
bath chamber.
Puriﬁed Ataxin-1 proteins employed in Tip–Dip assays were made
up to a ﬁnal concentration of approximately 20 nM in a solution con-
taining: 144 mM KCl, 0.1 mM CaCl2, 1.2 mM MgCl2, 1.1 EGTA, 10 mM
Hepes, pH 6.2 and DMSO 55%. Two microliters of this solution was
added to 1 ml of the test solution.
Patch clamp electrophysiology was performed in cell-attached
conﬁguration on nuclear inner membrane. Nuclei were isolated by
centrifugation sequences on a sucrose gradient starting from a cell
homogenate and then exposed for 1 h to a 1% Citrate containing solu-
tion. According to an old procedure [36] revisited by Gilchrist and col-
leagues [37], puriﬁcation of nuclei in citrate-containing buffers leads
to preferential removal of the outer nuclear membrane.
GFP ﬂuorescence, detected by a Zeiss Axiovert 100 ﬂuorescent mi-
croscope, allowed recognition of transfected nuclei for electrophysio-
logical experiments. The bath solution was (in mM): 144 KCl, 0.1
CaCl2, 1.2 MgCl2, 1.1 EGTA, 10 Hepes, and pH 6.2. The cell-attached
electrode was ﬁlled with the same solution. The Axopatch 200 B am-
pliﬁer and pClamp 9 acquisition software (both from Molecular
Device, Novato, CA) were used to record and analyze the single-
channel. Current recordings were digitized at 5 kHz and ﬁltered at
1000 Hz. The single channel conductance was determined by linear
regression of the i/V relationships.
Data are presented as mean±SEM. Values obtained from different
experiments were tested for statistical differences using an
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Northampton, MA).
3. Results
In this study normal and pathological ATXN1 alleles have been
employed. The normal allele 31Q(H) is one of the most frequent al-
leles in humans, while 45Q(H) is an uncommon allele containing 45
repeat units. Although the length of the latter is well within the
range of expansions, two blocks of CAT-CAG-CAT interruptions
(HQH at the protein level) suppress the pathological effects of the ex-
pansion [2,7]. The pathological alleles were represented by two ex-
panded SCA1 containing 45 and 76 uninterrupted CAG repeat units
(45Q and 76Q). It is worth noting that 45Q(H) and 45Q alleles are
of the same length, but while the latter causes the disease, the former
does not. These alleles represent a molecular model making it possi-
ble to discriminate between causative effects of pathogenic polyQ ex-
pansions and epiphenomena merely due to the length of the polyQ
tract.
3.1. Aggregation and cell death in mammalian cells expressing normal
and expanded ATXN1
COS1 cells were transfected with ATXN1 full length proteins con-
taining 31Q(H), 45Q(H), 45Q or 76Q repeat segments fused to an en-
hanced ﬂuorescent protein (EGFP). All these proteins are prone to
form aggregates, but this feature increases with the repeat length.
In fact, we found that the majority of COS1 cells transfected with nor-
mal ATXN1-31Q(H) showed a diffuse staining accompanied by many
small aggregates; by contrast, cells transfected with mutant ATXN1-
76Q contained fewer nuclear aggregates much larger in size, match-
ing previous data from similar experiments [38]. The images obtained
from cells transiently transfected with ATXN1-45Q showed anFig. 1. Analysis of transiently transfected COS1 cells with ATXN1 full length proteins conta
polyQ stretches is observed as compared to polyQ(H). (A) Example of anomalous nuclei, sh
stained with the nuclear dye DAPI (top row), cells expressing EGFP/ATXN1 (middle row) and
ing out of the nucleus (blue stain) indicated by the red arrows. This suggests a nuclear enve
clear morphology after 48 h. ***P⋘0.01.intermediate behavior, characterized by many cells with a diffuse
staining of the nucleus accompanied by large aggregates. Interesting-
ly, results obtained from cells transfected with ATXN1-45Q(H) were
very similar to those obtained with ATXN1-45Q (data not shown).
The toxicity of the four constructs was tested by morphological
analysis of transiently transfected COS1 cells. Cells expressing polyQ
presented a signiﬁcantly higher frequency (chi square=23.35;
P≪0.001) of anomalous nuclei with respect to those expressing
polyQ(H) (Fig. 1). Interestingly the two normal alleles, 31Q(H) and
45Q(H), produced similar results, thus supporting the hypothesis
that the toxicity of polyQ stretches depends on the particular struc-
ture formed by pure glutamine repeats.
3.2. Morphological analyses of nuclear membrane
To investigate whether expanded ATXN1 interacts with the nucle-
ar membrane we carried out an immunoﬂuorescence study using a
marker for the inner nuclear envelope. Emerin is a serine-rich inner
nuclear membrane protein and a member of the nuclear lamina-
associated protein family [39]. COS1 cells were transfected with vec-
tors for the expression of the EGFP and fusion proteins of EGFP and
full length ATXN1-31Q(H), -45Q(H), -45Q and -76Q. DAPI was used
to detect nuclei while nuclear membranes were visualized by an
anti-emerin antibody detected by a TRITC-conjugated secondary anti-
body (red). Cells transfected with EGFP showed a diffuse green color
in the nucleus and the cytoplasm, most of them displaying the usual
emerin localization at the nuclear membrane level. In contrast, all
cells expressing EGFP/ATXN1 fusion proteins showed the green
color to be limited to the nucleus, as expected because of the
ATXN1 NLS (Fig. 2A); a large emerin loss surrounding the nucleus
was observed in cells expressing ATXN1-45Q and 76Q.
The immunoﬂuorescence results indirectly suggest that severe
damage occurs in the nuclear membrane of cells expressing ATXN1-ining 31Q(H), 45Q(H), 45Q or 76Q repeat segments. Signiﬁcantly stronger toxicity of
owing pyknosis or fragmentation, indicated by white arrows. The pictures show cells
merged images (bottom row). In the merged panels, note the green ﬂuorescence com-
lope leakage. (B) Percentages of transfected COS1 cells showing marked abnormal nu-
Fig. 2. Cells expressing expanded ATXN1 show a marked damage of the nuclear envelop. COS1 cells were transfected with pEGFP/ATXN1 fusion proteins containing 31Q(H), 45Q or
76Q repeat segments (Panels A). After 48 h they were ﬁxed and stained with anti-emerin (red ﬂuorescence). Arrows indicate transfected cells showing loss of emerin. Transmission
electron micrographs (Panels B) showing the ultrastructure of COS1 cells transfected with ATXN1-31Q(H), or ATXN1 proteins containing 45Q or 76Q repeat segments. Cells expres-
sing ATXN1-31Q(H) (a, b) show normal appearance with oval shaped nuclei and intact nuclear double membrane (b). Cells transfected with expanded ATXN1-45Q (c, d) display
changes of nuclear morphology characterized by profound invaginations and nuclear indentations (arrows) (d). In cells transfected with expanded ATXN1-76Q (e, f) abnormalities
consist in deeply convoluted nuclear proﬁle with breakages into the nuclear envelope (arrows) (f). N = nucleus. Original magniﬁcations: (a, e) 7000×; (b) 30000×; (c) 20000×;
(d, f) 50000×.
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also analyzed these cells with electron microscopy (Fig. 2B). Profound
invaginations and discontinuities of the nuclear envelope were ob-
served in a large number of COS1 cells expressing ATXN1-45Q and
76Q. Overall, these results suggest a toxic action of expanded polyglu-
tamines on the membranes.
3.3. Mechanical properties of artiﬁcial membranes in the presence of
different forms of partial ATXN1 peptides
To model the interaction between ATXN1 and the nuclear mem-
brane, we performed experiments on artiﬁcial bilayers containing
uninterrupted or interrupted partial ATXN1 peptides. The latter
were mixed with the lipids before membrane preparation. AFM in-
spection of the pATXN1 variants before mixing with the lipids
showed the presence of bead-like structures which can be identiﬁed
with monomers and oligomers (not shown). The mean height of
these structures is 1.2±0.1 nm for pATXN1-32Q(H), 1.9±0.1 nm
for pATXN1-45Q(H) and 1.8±0.1 nm for pATXN1-45Q. Taking into
account the very low concentration of pATXN1 peptides in the mem-
brane (2 nM), it is likely that most of the peptides remained in the
monomeric or at most in the oligomeric state.
Liposomes containing pATXN1-31Q(H), -45Q(H) or -45Q were de-
posited on freshly cleaved mica to form self-assembled planar bila-
yers. These have been imaged using tapping mode AFM. In
membranes containing pATXN1-45Q(H) and -45Q round-shaped
islands are visible (Fig. 3A, B). The islands observed for pATXN1-
45Q(H) and -45Q have different features. In particular, for pATXN1-
45Q most of the structures observed are islands whose diameterwas 32±7 nm. These islands do not protrude from the membrane
surface; therefore their size is not inﬂuenced by AFM tip effects
(Fig. 3A). A different behavior is observed in membranes containing
pATXN1-45Q(H). In this case round-shaped objects protruding from
the membrane are visible (Fig. 3A, inset). Their apparent diameter is
11±4 nm and their height with respect to the membrane surface is
0.50±0.06 nm. As these objects protrude from the membrane sur-
face, their size in the scan plane is affected by the AFM tip size. Cor-
rection factors are discussed in the “Materials and methods”
section; taking into account the correction factor, the real object
size is in the order of a few nanometers. The difference between
islands formed by pATXN1-45Q and pATXN1-45Q(H) is evidenced
by tapping mode phase imaging. In fact, islands associated to
pATXN1-45Q display very different mechanical properties compared
to the membrane in which they are embedded (Fig. 3B). Conversely,
from a mechanical point of view, islands associated to pATXN1-
45Q(H) cannot be distinguished from the background (Fig. 3B,
inset). Fig. 3D compares island proﬁles measured in the two cases
from cross sections of the corresponding topographic AFM images.
Membranes containing pATXN1-31Q(H) showed a behavior similar
to those with pATXN1-45Q(H). Round-shaped islands were observed
protruding from the membrane, with a height of 0.6±0.1 nm and an
apparent diameter of 18±3 nm (results not shown).
Round-shaped islands are absent in pure lipid membranes
(Fig. 4D); in addition, the islands are homogenous in shape and size.
This suggests that they can be identiﬁed as protein or protein–lipid
complexes inserted in the membrane. We found a different behavior
for non-pathological and pathological peptides, with islands protrud-
ing from the membrane in the former case and completely embedded
Fig. 3. Tapping mode AFM images of artiﬁcial membranes containing pATXN1 peptides. (A) Topographic image of a membrane containing pATXN1-45Q. Inset: topographic image of
a membrane containing pATXN1-45Q(H). (B) Phase images of the same regions reported in (A). (C) Height proﬁle obtained for the membrane containing pATXN1-45Q, showing
that islands do not protrude from the background. (D) Height proﬁle obtained for the membrane containing pATXN1-45Q(H) and showing an island protruding from the back-
ground. Proﬁles (C) and (D) were obtained from the image sections traced along the green line in (A) and blue line in inset (A) respectively. (E) topographic image of a pure
lipid membrane. Scan size (A), (B), (E), 830 nm; insets, 160 nm. Z range (A) and inset (A), 3.0 nm; (E), 8.0 nm.
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porting the conclusion that islands are indeed protein or lipid–
protein complexes, and is in agreement with the electrophysiological
experiments reported in the next section, showing a different
membrane permeabilization induced by pathological and non-
pathological peptides.
While imaging of pure lipid membranes and membranes contain-
ing pATXN1-31Q(H) was easily achieved, obtaining images of mem-
branes with pATXN1-45Q(H) was more difﬁcult; indeed, in the case
of membranes with pATXN1-45Q it was extremely difﬁcult, suggest-
ing an increased instability of the system as the peptide toxicity is in-
creased. To quantify this behavior, we performed force-distance
measurements to obtain the force required to penetrate the mem-
brane with the AFM tip. This measurement made it possible to obtain
information about the mechanical resistance of the membrane; the
lower the penetration force, the more fragile is the membrane.
Fig. 4A shows a typical force-distance curve measured as the tip grad-
ually approaches the supported membrane. When the tip is far from
the surface, no interaction occurs; this corresponds to the horizontal
region in the curve of Fig. 4A. The linear region corresponds to contact
between tip and sample, resulting in a cantilever deﬂection, and
therefore the interaction force, proportional to the sample advance-
ment. When the force reaches a critical value, the tip penetrates the
membrane; such a yielding force is indicated by the double arrow in
Fig. 4A. Membrane penetration corresponds to a sudden force de-
crease in the force-distance curve. The distributions of yielding forcesfor pure lipid membranes and membranes containing different
pATXN1 peptides are reported in Fig. 4B–E. Interestingly, the distribu-
tion of yielding forces for membranes containing pATXN1-31Q(H) is
shifted towards lower values as compared to that of the pure lipid.
A further shift is observed for membranes containing pATXN1-
45Q(H), while the largest shift occurs for membranes containing
pATXN1-45Q. These results indicate that membrane destabilization
increases as the peptide toxicity is increased.
3.4. Electrical properties of artiﬁcial and biological membranes in the
presence of different forms of polyQ expanded ATXN1
The results of the experiments on the mechanical properties of
lipid bilayers exposed to pATXN1 peptides clearly suggest that these
peptides are able to interact with biological membranes. The nature
of this interaction appears to be functional as well as structural. The
bilayer mechanical parameters are affected by the number of gluta-
mine repeats in the protein under observation. The more expanded
are the polyQ tails interacting with the bilayer, the more fragile is
the membrane (Fig. 4). From the functional point of view, this result
suggests that membranes interacting with a higher number of gluta-
mine repeats should have a lower electrical resistance and, conse-
quently, be more permeable to ions. Fig. 5 presents measurements
of membrane permeability obtained in artiﬁcial membranes contain-
ing different types of expanded pATXN1 peptides, clamped to 80 mV.
As in AFM experiments, the peptides were mixed with the lipids
Fig. 4. (A) Typical force-distance curve measured on a supported lipid membrane. The horizontal region corresponds to absence of interaction between the AFM tip and the sample.
In the linear region the interaction between tip and sample increases with the tip advancement. The jump in the curve indicates membrane penetration; the corresponding yielding
force is indicated by the double arrow. (B–E) Distributions of yielding forces showing that the mean yielding force of artiﬁcial membranes containing pATXN1 peptides decreases as
the peptide toxicity is increased. (B) Pure lipid bilayers; (C–E) bilayers containing (C) pATXN1-31Q(H), (D) pATXN1-45Q(H), (E) pATXN1-45Q.
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in Panel A clearly show higher activity for pATXN1-45Q and -76Q
compared to pATXN1-31Q(H) and pATXN1-45Q(H). The electrical ac-
tivity was quantiﬁed by analyzing the number of current levels for the
different polyQ types. It is evident from Fig. 5A that a higher number
of glutamine repeats correspond to a higher number of current levels.
This is even more evident in the amplitude histograms plotted in
Fig. 5B: pATXN1-45Q and -76Q plots show a larger number of events
and display higher amplitudes compared to pATXN1-31Q(H) and
-45Q(H). This higher activity results in enhanced membrane perme-
ability, as shown by current/voltage plots in Fig. 5C. The slope of the
i/V curves increases progressively from pATXN1-31Q(H) to -76Q. In-
terestingly, a large difference in conductance is undoubtedly visiblebetween the histidine-interrupted and uninterrupted peptides. In
particular, lipid membranes containing pATXN1-45Q show an aver-
age conductance whose value is almost double compared to those
with the histidine interrupted form.
The results presented above suggest that polyQ chains are able to
lower the bilayer electrical resistance. Furthermore, the longer the
polyQ tail, the lower appears the membrane resistance. The immuno-
stain experiments (Fig. 2) show that in transfected COS1 cells, ATXN1
accumulates in the nucleoplasm. Co-localization experiments suggest
a close relationship between polyQ proteins and the nuclear inner
membrane (Fig. 2). This raises the question whether there is a func-
tional interaction between the internal membrane of the envelope
and polyQ proteins. After 48 h from the transfection using pIRES-
Fig. 5. Electrical behavior of artiﬁcial membranes containing different pATXN1 peptides. (A) Current traces recorded at 100 mV membrane potential in Tip Dip experiments using
artiﬁcial lipid bilayers containing 20 nM of the indicated pATXN1 peptide. (B) Amplitude histograms of the corresponding current levels. Larger current levels are measured for the
uninterrupted peptides. The current/voltage relationships in (C) show the averages of 20 current recordings at 10 different test potential for each polyQ type.
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length recombinant ATXN1 proteins were identiﬁed by GFP ﬂuores-
cence. Cell nuclei were isolated and the outer membrane was gently
removed by a chemical treatment (see Materials and methods for de-
tails). This procedure eliminated the external membrane of the nucle-
ar envelope on 90% of the total nuclei surface. At the top of Fig. 6 we
show electron microscopy pictures of isolated nuclei in control condi-
tions (A) and after the removal of the outer membrane (B). Ultra-
structure of pIRES-ATXN1-31Q(H) and -45Q(H) transfected nuclei
was substantially similar. The possibility to test 76Q polyQ trans-
fected COS1 nuclei was hampered by the paucity of living cells after
24–48 h from the transfection. What is intriguing is the comparison
between consecutive and interrupted polyQ with the same number
of repeats, such as the 45Q(H) and 45Q constructs, which showed a
signiﬁcant difference in toxicity experiments (Fig. 1). Patch clamp
measurements on both preparations yielded single-channel record-
ings which conﬁrmed the data previously described in Tip Dip exper-
iments. Fig. 6 clearly shows a higher number of current levels in 45Q
transfected nuclei compared to 45Q(H). The amplitude histograms
plotted in Fig. 6C depict a number of current peaks doubled for 45Q
compared to 45Q(H). Membrane interaction of the uninterrupted
ATXN1 protein not only prompted a higher number of current levels,
but also showed a larger amplitude of the single current level com-
pared to the 45Q(H). To further characterize these patch recordings,
we analyzed the current traces in more detail. We measured and av-
eraged the amplitude of each single current level at the different
membrane potentials applied. Fig. 7 shows examples of single chan-
nel recordings at +80 mV membrane voltage. The values of single
current steps at the same potential were in general homogeneous,mainly at the beginning of the experiment. The bottom of Fig. 7 de-
picts i/V relationships for the average current levels using each re-
combinant protein type (n=4). On the left side, ﬁtting the
experimental current values at different membrane potentials
resulted in a conductance slope of 11.0±0.3 pS relative to 45Q(H)
polyQ proteins. On the right, the calculated average conductance for
45Q protein is 25.0±0.7 pS.
The difference in conductance could reﬂect a difference in ionic se-
lectivity. However, the membrane current pathways show the same
permeability to sodium, potassium or chloride (data not shown).
Thus, monovalent ions are not discriminated by the permeability
caused by the polyQ interaction with the biological membranes. By
contrast, divalent ions act differently in the presence of 45Q(H) and
45Q. While histidine-interrupted polyQs are virtually insensitive to
different calcium concentrations, 45Q exhibits a conductance
depending on the divalent ion concentration. Fig. 8A shows two i/V
curves from 5 different single-channel recordings. The linear regres-
sion curves of the current values obtained from nuclei transfected
with the 45Q(H) protein at two different calcium concentrations
(Fig. 8A left) are virtually coincident (n=5, t test pb0.0001). The
conductance in low and high calcium concentration was 12±2 pS
and 12±1 pS, respectively. However, in nuclei of cells transfected
with the 45Q construct, the single current levels increased in ampli-
tude following the increase of calcium concentration. The conduc-
tance changed from 23±2 pS in 1.8 mM calcium to 32±1 pS in
10 mM calcium (Fig. 8A right; n=5, pb0.0006). Examples of current
recordings in the two different experimental conditions are shown in
Fig. 8B. The histograms in Fig. 8C show that the average amplitude
current levels are statistically different between 45Q and 45Q(H) in
Fig. 6. Patch-clamp recordings on the inner nuclear membrane of COS1 cells transiently transfected with ATXN1 full length proteins. (A) Electron microscopy pictures of isolated
nuclei and (B) nuclei treated for 1 h with Citrate to remove the outer membrane of the envelope. (C) Current recordings obtained on the inner nuclear membrane at−80 mV po-
tential applied in the patch-pipette (top). Nuclei were isolated from control cells transfected with the GFP vector only (left), with 45Q(H) (center) and 45Q (right). At the bottom of
panel C we show three examples of current amplitude distribution corresponding to the three different preparations. A total of 10 s continuous recording was analyzed at each
membrane potential using a commercial software (see Materials and methods). Negative histogram peaks corresponding to the current levels visualized in the patch-clamp reg-
istrations above are completely absent in the control GFP (inset).
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also showed a pronounced increase in the membrane conductance
when the calcium concentration was raised to 10 mM (n=6,pb0.0001). Collectively, the electrophysiological measurements
show that the conductance of 45Q(H) is insensitive to the calcium
concentration. By contrast, 45Q not only shows a higher conductance
Fig. 7. Single event conductance obtained from current recordings on the inner nuclear
membrane of COS1 cells transiently transfected with ATXN1 full length proteins. Cur-
rent traces at 80 mV membrane voltage are shown in the top panels for interrupted
(left) and 45Q (right). Corresponding current/voltage relationships are plotted at the
bottom of the ﬁgure. The average conductance is 11.0±0.3 pS for 45Q(H) and 25.0±
0.7 pS for 45Q.
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increase as the calcium concentration is increased. The ratio between
average current levels measured for 45Q and 45Q(H) has similar
values of 2.1±0.2 for tip dip and 1.9±0.1 for patch clamp
experiments.
4. Discussion
Although the genetic basis of polyQ diseases, and more speciﬁcally
of SCA1, was recognized about twenty years ago, their molecular basis
is still controversial. Several issues are still open regarding the polyQ
pathogenesis, in particular i) whether the speciﬁc structure of ex-
panded polyQ results in toxicity to cells; ii) how the expanded
polyQ proteins cause neurodegeneration. A number of proteins inter-
act with ATXN1. Among these proteins there are several transcrip-
tional regulators, including the corepressor SMRT (silencing
mediator of retinoid and thyroid hormone receptors), Drosophila
SENS (Senseless) and its mammalian homolog Gﬁ1 (growth factor-
independent 1), the human homolog of the Drosophila repressor
CIC (Capicua), and the RORα-Tip60 complex (reviewed in [1]).
These data could suggest that mutant ATXN1 affects the normal reg-
ulation of the cell metabolism. Nevertheless, the neurodegeneration
caused by expanded polyglutamines is a complex pathology and it
is likely that more than one mechanism contribute to SCA1 disease.
Recently, Duvick et al. [26] showed that a SCA1-like disease in
mice is induced by a single aminoacid substitution in ATXN1 protein
disrupting a phosphorylation site. However, the point mutation failed
to cause any neurodegenerative process. Cell death only occurred in
the presence of an expanded polyQ tract. These results support a
model in which the pathogenesis of SCA1 is based on at least two dif-
ferent molecular mechanisms, involving induction of disease in Pur-
kinje cells on the one hand and neuronal degeneration on the other.
The aim of our work is to gain new insight into the relation between
expanded polyQs and neurodegeneration. To this purpose, wefocused on the interaction between expanded ATXN1 and lipid mem-
branes. We carried out experiments both on cellular models trans-
fected with full length ATXN1 and on artiﬁcial lipid bilayers
containing polyQ peptides. Although in these cellular models ATXN1
is overexpressed, transgenic mice carrying exogenous overexpressed
expanded ATXN-1 recapitulate disease pathology with characteristic
behavioral phenotypes [40], thus suggesting that overexpression
does not alter the accumulation pathway.
We compared expanded pathological (polyQ) and interrupted
(polyQ(H)) non-harmful polyglutamine tracts. In particular, we con-
sidered pathological and non-pathological ATXN1 variants of the
same length. This allowed us to discriminate between toxic effects ac-
quired by consecutive CAG repeats and epiphenomena due to the
overall length of the expansion. In fact, ATXN1-45Q(H) is a normal
form of the protein prone to forming nuclear aggregates at an extent
comparable with the pathological ATXN1-45Q of the same length,
when expressed in COS1. However, these two variants displayed a re-
markable difference in toxicity (Fig. 1). It has been suggested that the
ability of histidine insertion to suppress expanded polyQ toxicity does
not lie in a reduced recruitment activity of the resulting amyloid ag-
gregates [41], but rather in an altered pathway of spontaneous aggre-
gation, still not clearly characterized in vivo. Thus, the reduced
toxicity may derive, not from reduced aggregation rates, but because
of some critical change in aggregate properties.
Due to the combination of polyQ ability to interact with mem-
branes [27,28] and ATXN1 localization in the nucleus, it is expected
that the pathological activity involves the inner nuclear membrane.
Indeed immunoﬂuorescence and electron microscope images of
transfected cells showed a remarkable nuclear membrane disruption.
The extent of this phenomenon is correlated with the number of
uninterrupted glutamines (Fig. 2).
Atomic force microscopy images of artiﬁcial membranes showed a
different arrangement of the interrupted and non-interrupted pep-
tide within the lipid bilayer, indicating a deeper insertion of the path-
ological variant in the membrane. This gave rise to the formation of
defects in the lipid ﬁlm, which were also revealed by changes in the
mechanical properties of the membrane. The longer the uninter-
rupted glutamine stretch, the more fragile was the membrane
(Figs. 3 and 4).
The presence of transient defects in the membranes upon inser-
tion of polyQ peptides was clearly shown by transmembrane electri-
cal measurements. Both artiﬁcial lipid bilayers and cellular models
demonstrated the dynamic appearance of ionic pathways. Uninter-
rupted polyQs showed not only a larger ionic ﬂow, but also an in-
crease in the single event conductance. This suggests the transient
formation of larger membrane gaps.
It is well known that several misfolded proteins, even if unrelated
in their primary sequence, are able to self-aggregate into a similar
amyloid structure [42]. It has also been reported that the interaction
of amyloids with biological membranes reduces the membrane elec-
trical resistance [43–46]. In this work we show that polyQs, whether
interrupted or not, exhibit single channel-like behavior both in artiﬁ-
cial lipid bilayers (Fig. 5) and in cell nuclear membranes (Fig. 6). Hir-
akura and colleagues [27] calculated a conductance range of 19 to
220 pS for the polyQ non-selective channel in planar lipid bilayers.
In Tip Dip experiments we found single current level conductance be-
tween 20 and 350 pS for pathological 45Q protein and between 20
and 550 pS for 76Q polyQ, while the range for non-pathological
forms of ATXN1 (31Q(H) and 45Q(H)) was from 11 to 140 pS.
The conductance values resulting from cell-attached experiments
on the inner nuclear membrane exhibit a much lower variability.
Comparing current recordings of transfected COS1 cells, it is possible
to calculate a single current level conductance of 11 pS for 45Q(H)
and 25 pS for 45Q (Fig. 7). In addition, the non-pathological inter-
rupted ATXN1 isoform induces not only lower conductance levels
(Figs. 5 and 6), but also a reduced membrane fragility (Fig. 4) as
Fig. 8. Calcium ions permeability of the inner nuclear membrane of COS1 cells transiently transfected with ATXN1 full length proteins. (A) current/voltage relationships of patch-
clamp current recordings in 1.8 and 10 mM CaCl2 for 45Q(H) (left) and 45Q (right). The linear regression curves of the experimental points are superimposed in the case of 45Q(H)
showing a similar conductance. By contrast, the calculated i/V conductance for 45(Q) shows different slopes for different calcium concentrations. (B) Individual current traces at
two different test potentials showing that single current events are similar in low and high calcium for 45Q(H) (left) while they are markedly different for 45Q (right). (C) Com-
parison between conductance values obtained at different Calcium concentrations for 45Q(H) and 45Q. The histogram highlights the difference between 45Q and 45Q(H) in low
calcium (n=5, pb0.001). 45Q-transfected nuclei in addition show a pronounced increase in the membrane conductance when the calcium concentration was raised to 10 mM
(n=6, pb0.001).
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greater ability to permeabilize lipid bilayers (Figs. 5 and 6), is able
to double the conductance of the single measurable event both in ar-
tiﬁcial as well as in biological membranes (Figs. 7 and 8). Since the
ratio between average current levels measured for 45Q and 45Q(H)
has similar values for both artiﬁcial bilayers and nuclear membranes,
we suggest that the lipid composition does not play a crucial role in
the ionic ﬂow induced by the two ATXN1 variants. Collectively, our
results from AFM and electrophysiological measurements suggest
that these peptides cause transient bilayer defects, acting as unspeci-
ﬁc ionic pathways. Whether a progressive permeabilization of the
inner nuclear membrane represents an early event in the disease pro-
gression it is not clear. It is possible that change in conductance of the
inner nuclear membrane is a parallel effect of the pathological pheno-
type insurgency. It appears well established that the disease exordi-
um characterized by neuronal dysfunctions is distinct from the
neurodegenerative process [26]. In this context, overproduction and
nucleoplasm accumulation of misfolded ATXN1 certainly anticipate
neuronal death.
Of note, in marked contrast with 45Q, 45Q(H) does not change its
conductance value when the calcium concentration is changed
(Fig. 8). On the basis of AFM images, we can speculate that this differ-
ent behavior lies in the different 3D arrangement of the interrupted
and uninterrupted polyQ in the membrane. The different permeabili-
ty properties of the pathological and the non-pathological ATXN1 iso-
forms could certainly account for the different levels of cell toxicity
showed in Fig. 1. It is expected that ATXN1 has a preferential interac-
tion with the inner nuclear membrane due to preferential proteinaccumulation in the nucleoplasm [9]. Opening unregulated ionic
pathways permeable to calcium in the inner nuclear membrane by
uninterrupted polyQ is certainly dangerous for the genetic material
structure and function, giving rise to progressive cellular damage.
All the results here described are consistent with the clinical ob-
servation of a negative correlation between the length of the expan-
sion and both the age at onset and the duration of the disease.
Uncovering the pathogenic mechanism underlying the disease
opens up the possibility of designing a strategy to cure, or at least
delay, the disease symptoms. The process that we have highlighted
with our experiments demonstrates that the interaction between
pathological molecules and the nuclear membrane is responsible for
the end point of cell degeneration. It is likely that at this stage the
cell damage cannot be recovered. To prevent the cell death it is crucial
to interrupt the process before polyQs are accumulated within the
nucleus, so avoiding their interaction with the inner membrane.
Therefore, a therapy for recovery would be effective if it addresses
the early stages of the neurodegenerative process.Author contributions
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